Bio

Jeffrey Low joined Novo Growth in 2020 as a principal. Jeffrey focuses on investments in the life sciences and technology and is based in our San Francisco office. He joins us from Andreessen Horowitz where he established the firm’s therapeutics practice and actively invested at the intersection of life sciences, healthcare, and technology. Jeffrey holds an MD from Yale School of Medicine, an MBA from Harvard Business School, and an AB in Molecular and Cellular Biology from Harvard University.